Global Acute Myeloid Leukemia Market Research Report 2023

Leukemia are a heterogeneous group of cancers affecting the bone marrow and White Blood Cells (WBC). Leukemia is characterized by the rapid increase of abnormal blood cells growth or blasts, resulting in a decrease in the numbers of healthy, normal fully modified blood cells, leading to the typical symptoms of bleeding, anemia, and high risk of infection. 

The global Acute Myeloid Leukemia market was valued at US$ 1516.9 million in 2022 and is anticipated to reach US$ 3158.1 million by 2029, witnessing a CAGR of 13.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Primary drivers boosting the growth of acute myeloid leukemia (AML) therapeutics market are minimal but increased prevalence of acute myeloid leukemia (AML), increased drug approval rate for AML, classification of acute myeloid leukemia (AML) as an orphan disease. Over the forecast period, population of people over 65 year is anticipated to increase, which is another key driver for acute myeloid leukemia (AML) therapeutics market.

This report aims to provide a comprehensive presentation of the global market for Acute Myeloid Leukemia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Myeloid Leukemia.

The Acute Myeloid Leukemia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Acute Myeloid Leukemia market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Acute Myeloid Leukemia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acute Myeloid Leukemia Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Chemotherapy

1.2.3 Radiation Therapy

1.2.4 Stem Cell Transplant

1.2.5 Targeted Therapy

1.2.6 Others

1.3 Market by Application

1.3.1 Global Acute Myeloid Leukemia Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Retails Drug Stores

1.3.4 Ambulatory Care Centers

1.3.5 Oncology Centers

1.3.6 Clinics

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Acute Myeloid Leukemia Market Perspective (2018-2029)

2.2 Acute Myeloid Leukemia Growth Trends by Region

2.2.1 Global Acute Myeloid Leukemia Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Acute Myeloid Leukemia Historic Market Size by Region (2018-2023)

2.2.3 Acute Myeloid Leukemia Forecasted Market Size by Region (2024-2029)

2.3 Acute Myeloid Leukemia Market Dynamics

2.3.1 Acute Myeloid Leukemia Industry Trends

2.3.2 Acute Myeloid Leukemia Market Drivers

2.3.3 Acute Myeloid Leukemia Market Challenges

2.3.4 Acute Myeloid Leukemia Market Restraints

3.1 Global Top Acute Myeloid Leukemia Players by Revenue

3.1.1 Global Top Acute Myeloid Leukemia Players by Revenue (2018-2023)

3.1.2 Global Acute Myeloid Leukemia Revenue Market Share by Players (2018-2023)

3.2 Global Acute Myeloid Leukemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Acute Myeloid Leukemia Revenue

3.4 Global Acute Myeloid Leukemia Market Concentration Ratio

3.4.1 Global Acute Myeloid Leukemia Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Revenue in 2022

3.5 Acute Myeloid Leukemia Key Players Head office and Area Served

3.6 Key Players Acute Myeloid Leukemia Product Solution and Service

3.7 Date of Enter into Acute Myeloid Leukemia Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Acute Myeloid Leukemia Historic Market Size by Type (2018-2023)

4.2 Global Acute Myeloid Leukemia Forecasted Market Size by Type (2024-2029)

5.1 Global Acute Myeloid Leukemia Historic Market Size by Application (2018-2023)

5.2 Global Acute Myeloid Leukemia Forecasted Market Size by Application (2024-2029)

6.1 North America Acute Myeloid Leukemia Market Size (2018-2029)

6.2 North America Acute Myeloid Leukemia Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Acute Myeloid Leukemia Market Size by Country (2018-2023)

6.4 North America Acute Myeloid Leukemia Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Acute Myeloid Leukemia Market Size (2018-2029)

7.2 Europe Acute Myeloid Leukemia Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Acute Myeloid Leukemia Market Size by Country (2018-2023)

7.4 Europe Acute Myeloid Leukemia Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Acute Myeloid Leukemia Market Size (2018-2029)

8.2 Asia-Pacific Acute Myeloid Leukemia Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2018-2023)

8.4 Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Acute Myeloid Leukemia Market Size (2018-2029)

9.2 Latin America Acute Myeloid Leukemia Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Acute Myeloid Leukemia Market Size by Country (2018-2023)

9.4 Latin America Acute Myeloid Leukemia Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Acute Myeloid Leukemia Market Size (2018-2029)

10.2 Middle East & Africa Acute Myeloid Leukemia Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2018-2023)

10.4 Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Celgene Corporation

11.1.1 Celgene Corporation Company Detail

11.1.2 Celgene Corporation Business Overview

11.1.3 Celgene Corporation Acute Myeloid Leukemia Introduction

11.1.4 Celgene Corporation Revenue in Acute Myeloid Leukemia Business (2018-2023)

11.1.5 Celgene Corporation Recent Development

11.2 Cephalon

11.2.1 Cephalon Company Detail

11.2.2 Cephalon Business Overview

11.2.3 Cephalon Acute Myeloid Leukemia Introduction

11.2.4 Cephalon Revenue in Acute Myeloid Leukemia Business (2018-2023)

11.2.5 Cephalon Recent Development

11.3 Clavis Pharma

11.3.1 Clavis Pharma Company Detail

11.3.2 Clavis Pharma Business Overview

11.3.3 Clavis Pharma Acute Myeloid Leukemia Introduction

11.3.4 Clavis Pharma Revenue in Acute Myeloid Leukemia Business (2018-2023)

11.3.5 Clavis Pharma Recent Development

11.4 Eisai

11.4.1 Eisai Company Detail

11.4.2 Eisai Business Overview

11.4.3 Eisai Acute Myeloid Leukemia Introduction

11.4.4 Eisai Revenue in Acute Myeloid Leukemia Business (2018-2023)

11.4.5 Eisai Recent Development

11.5 Genzyme Corporation

11.5.1 Genzyme Corporation Company Detail

11.5.2 Genzyme Corporation Business Overview

11.5.3 Genzyme Corporation Acute Myeloid Leukemia Introduction

11.5.4 Genzyme Corporation Revenue in Acute Myeloid Leukemia Business (2018-2023)

11.5.5 Genzyme Corporation Recent Development

11.6 Sunesis Pharmaceuticals

11.6.1 Sunesis Pharmaceuticals Company Detail

11.6.2 Sunesis Pharmaceuticals Business Overview

11.6.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Introduction

11.6.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2018-2023)

11.6.5 Sunesis Pharmaceuticals Recent Development

11.7 Abbvie

11.7.1 Abbvie Company Detail

11.7.2 Abbvie Business Overview

11.7.3 Abbvie Acute Myeloid Leukemia Introduction

11.7.4 Abbvie Revenue in Acute Myeloid Leukemia Business (2018-2023)

11.7.5 Abbvie Recent Development

11.8 Astellas Pharma

11.8.1 Astellas Pharma Company Detail

11.8.2 Astellas Pharma Business Overview

11.8.3 Astellas Pharma Acute Myeloid Leukemia Introduction

11.8.4 Astellas Pharma Revenue in Acute Myeloid Leukemia Business (2018-2023)

11.8.5 Astellas Pharma Recent Development

11.9 CTI Biopharma Corp

11.9.1 CTI Biopharma Corp Company Detail

11.9.2 CTI Biopharma Corp Business Overview

11.9.3 CTI Biopharma Corp Acute Myeloid Leukemia Introduction

11.9.4 CTI Biopharma Corp Revenue in Acute Myeloid Leukemia Business (2018-2023)

11.9.5 CTI Biopharma Corp Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Acute Myeloid Leukemia Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Chemotherapy

    Table 3. Key Players of Radiation Therapy

    Table 4. Key Players of Stem Cell Transplant

    Table 5. Key Players of Targeted Therapy

    Table 6. Key Players of Others

    Table 7. Global Acute Myeloid Leukemia Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Acute Myeloid Leukemia Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Acute Myeloid Leukemia Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Acute Myeloid Leukemia Market Share by Region (2018-2023)

    Table 11. Global Acute Myeloid Leukemia Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Acute Myeloid Leukemia Market Share by Region (2024-2029)

    Table 13. Acute Myeloid Leukemia Market Trends

    Table 14. Acute Myeloid Leukemia Market Drivers

    Table 15. Acute Myeloid Leukemia Market Challenges

    Table 16. Acute Myeloid Leukemia Market Restraints

    Table 17. Global Acute Myeloid Leukemia Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Acute Myeloid Leukemia Market Share by Players (2018-2023)

    Table 19. Global Top Acute Myeloid Leukemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia as of 2022)

    Table 20. Ranking of Global Top Acute Myeloid Leukemia Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Acute Myeloid Leukemia Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Acute Myeloid Leukemia Product Solution and Service

    Table 24. Date of Enter into Acute Myeloid Leukemia Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Acute Myeloid Leukemia Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Acute Myeloid Leukemia Revenue Market Share by Type (2018-2023)

    Table 28. Global Acute Myeloid Leukemia Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Acute Myeloid Leukemia Revenue Market Share by Type (2024-2029)

    Table 30. Global Acute Myeloid Leukemia Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Acute Myeloid Leukemia Revenue Market Share by Application (2018-2023)

    Table 32. Global Acute Myeloid Leukemia Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Acute Myeloid Leukemia Revenue Market Share by Application (2024-2029)

    Table 34. North America Acute Myeloid Leukemia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Acute Myeloid Leukemia Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Acute Myeloid Leukemia Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Acute Myeloid Leukemia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Acute Myeloid Leukemia Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Acute Myeloid Leukemia Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Acute Myeloid Leukemia Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Acute Myeloid Leukemia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Acute Myeloid Leukemia Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Acute Myeloid Leukemia Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Acute Myeloid Leukemia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Celgene Corporation Company Detail

    Table 50. Celgene Corporation Business Overview

    Table 51. Celgene Corporation Acute Myeloid Leukemia Product

    Table 52. Celgene Corporation Revenue in Acute Myeloid Leukemia Business (2018-2023) & (US$ Million)

    Table 53. Celgene Corporation Recent Development

    Table 54. Cephalon Company Detail

    Table 55. Cephalon Business Overview

    Table 56. Cephalon Acute Myeloid Leukemia Product

    Table 57. Cephalon Revenue in Acute Myeloid Leukemia Business (2018-2023) & (US$ Million)

    Table 58. Cephalon Recent Development

    Table 59. Clavis Pharma Company Detail

    Table 60. Clavis Pharma Business Overview

    Table 61. Clavis Pharma Acute Myeloid Leukemia Product

    Table 62. Clavis Pharma Revenue in Acute Myeloid Leukemia Business (2018-2023) & (US$ Million)

    Table 63. Clavis Pharma Recent Development

    Table 64. Eisai Company Detail

    Table 65. Eisai Business Overview

    Table 66. Eisai Acute Myeloid Leukemia Product

    Table 67. Eisai Revenue in Acute Myeloid Leukemia Business (2018-2023) & (US$ Million)

    Table 68. Eisai Recent Development

    Table 69. Genzyme Corporation Company Detail

    Table 70. Genzyme Corporation Business Overview

    Table 71. Genzyme Corporation Acute Myeloid Leukemia Product

    Table 72. Genzyme Corporation Revenue in Acute Myeloid Leukemia Business (2018-2023) & (US$ Million)

    Table 73. Genzyme Corporation Recent Development

    Table 74. Sunesis Pharmaceuticals Company Detail

    Table 75. Sunesis Pharmaceuticals Business Overview

    Table 76. Sunesis Pharmaceuticals Acute Myeloid Leukemia Product

    Table 77. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2018-2023) & (US$ Million)

    Table 78. Sunesis Pharmaceuticals Recent Development

    Table 79. Abbvie Company Detail

    Table 80. Abbvie Business Overview

    Table 81. Abbvie Acute Myeloid Leukemia Product

    Table 82. Abbvie Revenue in Acute Myeloid Leukemia Business (2018-2023) & (US$ Million)

    Table 83. Abbvie Recent Development

    Table 84. Astellas Pharma Company Detail

    Table 85. Astellas Pharma Business Overview

    Table 86. Astellas Pharma Acute Myeloid Leukemia Product

    Table 87. Astellas Pharma Revenue in Acute Myeloid Leukemia Business (2018-2023) & (US$ Million)

    Table 88. Astellas Pharma Recent Development

    Table 89. CTI Biopharma Corp Company Detail

    Table 90. CTI Biopharma Corp Business Overview

    Table 91. CTI Biopharma Corp Acute Myeloid Leukemia Product

    Table 92. CTI Biopharma Corp Revenue in Acute Myeloid Leukemia Business (2018-2023) & (US$ Million)

    Table 93. CTI Biopharma Corp Recent Development

    Table 94. Research Programs/Design for This Report

    Table 95. Key Data Information from Secondary Sources

    Table 96. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Acute Myeloid Leukemia Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Acute Myeloid Leukemia Market Share by Type: 2022 VS 2029

    Figure 3. Chemotherapy Features

    Figure 4. Radiation Therapy Features

    Figure 5. Stem Cell Transplant Features

    Figure 6. Targeted Therapy Features

    Figure 7. Others Features

    Figure 8. Global Acute Myeloid Leukemia Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Acute Myeloid Leukemia Market Share by Application: 2022 VS 2029

    Figure 10. Hospital Case Studies

    Figure 11. Retails Drug Stores Case Studies

    Figure 12. Ambulatory Care Centers Case Studies

    Figure 13. Oncology Centers Case Studies

    Figure 14. Clinics Case Studies

    Figure 15. Acute Myeloid Leukemia Report Years Considered

    Figure 16. Global Acute Myeloid Leukemia Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 17. Global Acute Myeloid Leukemia Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Acute Myeloid Leukemia Market Share by Region: 2022 VS 2029

    Figure 19. Global Acute Myeloid Leukemia Market Share by Players in 2022

    Figure 20. Global Top Acute Myeloid Leukemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia as of 2022)

    Figure 21. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Revenue in 2022

    Figure 22. North America Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. North America Acute Myeloid Leukemia Market Share by Country (2018-2029)

    Figure 24. United States Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Canada Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe Acute Myeloid Leukemia Market Share by Country (2018-2029)

    Figure 28. Germany Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. France Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. U.K. Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Italy Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Russia Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Nordic Countries Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific Acute Myeloid Leukemia Market Share by Region (2018-2029)

    Figure 36. China Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Japan Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. South Korea Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Southeast Asia Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. India Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Australia Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America Acute Myeloid Leukemia Market Share by Country (2018-2029)

    Figure 44. Mexico Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Brazil Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Acute Myeloid Leukemia Market Share by Country (2018-2029)

    Figure 48. Turkey Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Saudi Arabia Acute Myeloid Leukemia Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Business (2018-2023)

    Figure 51. Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Business (2018-2023)

    Figure 52. Clavis Pharma Revenue Growth Rate in Acute Myeloid Leukemia Business (2018-2023)

    Figure 53. Eisai Revenue Growth Rate in Acute Myeloid Leukemia Business (2018-2023)

    Figure 54. Genzyme Corporation Revenue Growth Rate in Acute Myeloid Leukemia Business (2018-2023)

    Figure 55. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Business (2018-2023)

    Figure 56. Abbvie Revenue Growth Rate in Acute Myeloid Leukemia Business (2018-2023)

    Figure 57. Astellas Pharma Revenue Growth Rate in Acute Myeloid Leukemia Business (2018-2023)

    Figure 58. CTI Biopharma Corp Revenue Growth Rate in Acute Myeloid Leukemia Business (2018-2023)

    Figure 59. Bottom-up and Top-down Approaches for This Report

    Figure 60. Data Triangulation

    Figure 61. Key Executives Interviewed